CLEERLY, WHOSE AI-POWERED IMAGING TECH AIMS TO PROVIDE A MORE COMPREHENSIVE VIEW OF CARDIAC HEALTH THAN TRADITIONAL INDICATORS, RAISES $43M SERIES B (CONOR HALE/FIERCEBIOTECH)